Publication | Closed Access

Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)

Diabetes ManagementDiabetesPharmacologyType 2PharmacotherapyDiabetes ComplicationsDiabetes MellitusSustain 10MedicineOnce-weekly Semaglutide 1.0